Organovo Inc. (ONVO)
Organovo Statistics
Share Statistics
Organovo has 17.45M shares outstanding. The number of shares has increased by 53.04% in one year.
Shares Outstanding | 17.45M |
Shares Change (YoY) | 53.04% |
Shares Change (QoQ) | 0.01% |
Owned by Institutions (%) | 13.56% |
Shares Floating | 17.12M |
Failed to Deliver (FTD) Shares | 5.21K |
FTD / Avg. Volume | 0.07% |
Short Selling Information
The latest short interest is 78.04K, so 0.51% of the outstanding shares have been sold short.
Short Interest | 78.04K |
Short % of Shares Out | 0.51% |
Short % of Float | 0.52% |
Short Ratio (days to cover) | 0.32 |
Valuation Ratios
The PE ratio is -0.64 and the forward PE ratio is -0.47. Organovo's PEG ratio is 0.03.
PE Ratio | -0.64 |
Forward PE | -0.47 |
PS Ratio | 86.42 |
Forward PS | 54.2 |
PB Ratio | 2.62 |
P/FCF Ratio | -0.64 |
PEG Ratio | 0.03 |
Enterprise Valuation
Organovo Inc. has an Enterprise Value (EV) of 5.59M.
EV / Earnings | -0.38 |
EV / Sales | 51.24 |
EV / EBITDA | -0.38 |
EV / EBIT | -0.37 |
EV / FCF | -0.38 |
Financial Position
The company has a current ratio of 2.12, with a Debt / Equity ratio of 0.39.
Current Ratio | 2.12 |
Quick Ratio | 1.96 |
Debt / Equity | 0.39 |
Total Debt / Capitalization | 27.91 |
Cash Flow / Debt | -10.51 |
Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is -4.07% and return on capital (ROIC) is -302.06%.
Return on Equity (ROE) | -4.07% |
Return on Assets (ROA) | -2.31% |
Return on Capital (ROIC) | -302.06% |
Revenue Per Employee | $7,785.71 |
Profits Per Employee | $-1,047,928.57 |
Employee Count | 14 |
Asset Turnover | 0.02 |
Inventory Turnover | n/a |
Taxes
Income Tax | 2K |
Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -30.1% in the last 52 weeks. The beta is 0.45, so Organovo's price volatility has been higher than the market average.
Beta | 0.45 |
52-Week Price Change | -30.1% |
50-Day Moving Average | 0.42 |
200-Day Moving Average | 0.56 |
Relative Strength Index (RSI) | 58 |
Average Volume (20 Days) | 7.87M |
Income Statement
In the last 12 months, Organovo had revenue of 109K and earned -14.67M in profits. Earnings per share was -1.6.
Revenue | 109K |
Gross Profit | 109K |
Operating Income | -15.09M |
Net Income | -14.67M |
EBITDA | -14.81M |
EBIT | -15.09M |
Earnings Per Share (EPS) | -1.6 |
Balance Sheet
The company has 2.9M in cash and 1.39M in debt, giving a net cash position of 1.51M.
Cash & Cash Equivalents | 2.9M |
Total Debt | 1.39M |
Net Cash | 1.51M |
Retained Earnings | -339.67M |
Total Assets | 3.84M |
Working Capital | -837K |
Cash Flow
In the last 12 months, operating cash flow was -14.65M and capital expenditures -42K, giving a free cash flow of -14.7M.
Operating Cash Flow | -14.65M |
Capital Expenditures | -42K |
Free Cash Flow | -14.7M |
FCF Per Share | -1.61 |
Margins
Gross margin is 100%, with operating and profit margins of -13.84K% and -13.46K%.
Gross Margin | 100% |
Operating Margin | -13.84K% |
Pretax Margin | -13.46K% |
Profit Margin | -13.46K% |
EBITDA Margin | -13.58K% |
EBIT Margin | -13.84K% |
FCF Margin | -13.48K% |
Dividends & Yields
ONVO does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | -222.22% |
FCF Yield | -116.93% |
Analyst Forecast
Currently there are no analyst rating for ONVO.
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Stock Splits
The last stock split was on Aug 19, 2020. It was a backward split with a ratio of 1:20.
Last Split Date | Aug 19, 2020 |
Split Type | backward |
Split Ratio | 1:20 |
Scores
Altman Z-Score | -135.21 |
Piotroski F-Score | 3 |